Topical Syndrom Withdrawal with Plasma Fusion Therapy
Innovative Skin Care Treatment
Topical Steroid Withdrawal is a skin affection that can take years to bring it back to its original condition. The Plasma Fusion Therapy can reduce this to several weeks with the use of an innovative technology called Cold Atmospheric Plasma (CAP). Our team is dedicated to providing the best care for your skin, utilizing cutting-edge techniques to ensure your skin's rejuvenation. We specialize in personalized treatment plans tailored to your unique needs, aiming to exceed your expectations and restore your skin's health and vitality.
​
Cold atmospheric plasma (CAP) has been studied for its potential to promote wound healing in patients with various types of wounds, including chronic wounds. A review article published in MDPI Applied Sciences reported that CAP has been shown to reduce microbial load without any known significant negative effects on healthy tissues. It has also been shown to have anti-tumour effect.
​
A study published in Hindawi evaluated the efficacy of CAP therapy on chronic wounds. The study reported that CAP therapy was effective in reducing the wound area and promoting wound healing.
Another study published in Frontiers in Physics summarized recent studies examining CAP applications for stimulating wound healing. The study reported that CAP provides a promising biophysical tool to address issues by applying physically created modalities to inactivate microorganisms and enhance wound healing.
In summary, CAP technology has shown great potential in wound healing. It has been shown to reduce microbial load without any known significant negative effects on healthy tissues and has been effective in reducing the wound area and promoting wound healing in patients with chronic wounds. Additionally, CAP has been shown to have anti-tumor effects .
The synergy between Cold Atmospheric Plasma and the management of chronic wounds, particularly in the context of Topical Steroid Withdrawal, holds immense promise. CAP's unique properties, including its selective pathogen targeting, tissue regeneration stimulation, and pain reduction capabilities, can significantly improve the outcomes for TSW patients. As researchers and healthcare providers continue to explore this synergy, we can anticipate more effective and personalized approaches to TSW wound care. This collaboration exemplifies the potential of cutting-edge technologies to address complex medical challenges and enhance the quality of life for individuals suffering from chronic wounds.
​
For more information, please refer to the TSW newsletter
​​
Experience the Transformation